Patrick Lu
Amministratore Delegato presso SIRNAOMICS LTD.
Patrimonio netto: 9 M $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Evans | M | 61 |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 17 anni |
| George Ji | M | - |
Guangzhou Natai Biomedical Technology Co., Ltd.
 Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012.
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 17 anni |
| Feng Mao Hua | M | 56 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 anni |
| Cheung Hoi Yu | M | 69 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 anni |
| Michael Vance Molyneaux | M | 54 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 anni |
| Xiao Chang Dai | M | 61 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 anni |
| Jun Lu | M | - |
Sun Yat-Sen University
| 38 anni |
| Mu Xian Sheng | F | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Mo Nin Ung | F | 55 | - | |
| Meng Ying Huang | F | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Mo Han Shing | F | 68 | - | |
| Danny Tang | M | - |
Guangzhou Natai Biomedical Technology Co., Ltd.
Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | 12 anni |
| Yong Xiang Wang | M | 71 | 4 anni | |
| Jian Kang Zhang | M | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Min Cong Huang | M | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| John Buergenthal | M | - | - | |
| James Topper | M | 62 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 18 anni |
| Min Cong Huang | M | 35 | 3 anni | |
| David Mack | M | 62 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 18 anni |
| Ting Cheung Leung | M | 41 | - | |
| Jacqueline A. Dombroski | M | - | - | |
| Michael Riley | M | - |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 18 anni |
| Jian Kang Zhang | M | 66 | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mohammad Azab | M | 68 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 4 anni |
| Da Jan Yang | M | 61 |
Sun Yat-Sen University
| 6 anni |
| Xiao Lin Dong | M | 73 |
Sun Yat-Sen University
| 6 anni |
| Kan Cheng Mai | M | 68 |
Sun Yat-Sen University
| 8 anni |
| Jun Liang | M | 59 |
Sun Yat-Sen University
| 7 anni |
| Yang Dajun | M | - |
Sun Yat-Sen University
| 5 anni |
| Xiaojing Dai | M | 64 |
Sun Yat-Sen University
| 7 anni |
| Wing Kei Yip | M | 39 | 6 anni | |
| Yi Xin Zeng | M | 62 |
Sun Yat-Sen University
| 4 anni |
| Wei Li Hong | M | 61 |
Sun Yat-Sen University
| 6 anni |
| Zhong Yang Yang | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Dong He | M | 57 |
Sun Yat-Sen University
| 3 anni |
| Min Huang | M | 59 |
Sun Yat-Sen University
| 4 anni |
| Yang Fei Zhong | M | 60 |
Sun Yat-Sen University
| 4 anni |
| Bin Zhao | M | 55 |
Sun Yat-Sen University
| 4 anni |
| Yi Jiang Zhuang | M | 60 |
Sun Yat-Sen University
| 4 anni |
| Chun Fai Kung | M | - |
Sun Yat-Sen University
| 4 anni |
| Jun Liu | M | 47 |
Sun Yat-Sen University
| 4 anni |
| Jian Fei Lin | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Qi Lin | M | 55 |
Sun Yat-Sen University
| 4 anni |
| Mei Zhen Li | F | 56 |
Sun Yat-Sen University
| 3 anni |
| Chao Hui Xu | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Guan Peng Li | M | 58 |
Sun Yat-Sen University
| 4 anni |
| Wen Qi Jiang | M | 67 |
Sun Yat-Sen University
| 1 anni |
| Yan Min Zhang | M | 68 |
Sun Yat-Sen University
| 4 anni |
| Xiao Ping Zong | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Tie Wei Luo | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Yu Qiang Sun | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Hong Bin Li | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Jian Guo He | M | 62 |
Sun Yat-Sen University
| 3 anni |
| Yun Zhang | F | 40 | 8 anni | |
| Qingzhen Zhang | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Fei Yang | M | 65 |
Sun Yat-Sen University
| 4 anni |
| Eping Liu | M | 61 |
Sun Yat-Sen University
| 1 anni |
| Ming Xie | M | 61 |
Sun Yat-Sen University
| - |
| Hong Bin Huang | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Chang Xu Zhu | M | 54 |
Sun Yat-Sen University
| 3 anni |
| Li Jian Xin | M | 68 |
Sun Yat-Sen University
| 4 anni |
| Wen Hui Xu | M | 54 |
Sun Yat-Sen University
| 4 anni |
| Michelle Xia | M | 57 |
Sun Yat-Sen University
| 3 anni |
| Ming Fong | M | 58 |
Sun Yat-Sen University
| 3 anni |
| Kui Zhang | M | 57 |
Sun Yat-Sen University
| 4 anni |
| Chun Rong Hu | M | 59 |
Sun Yat-Sen University
| 4 anni |
| Wei Chen | M | 56 |
Sun Yat-Sen University
| 5 anni |
| Chao Jiang | M | 53 |
Sun Yat-Sen University
| 4 anni |
| Steven Chamow | M | 70 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | - |
| Min Su | M | - |
Sun Yat-Sen University
| 4 anni |
| Ming Sang Yeung | M | - |
Sun Yat-Sen University
| 4 anni |
| Dennis Huang | M | 61 |
Sun Yat-Sen University
| 4 anni |
| Wubin Pan | M | 60 |
Sun Yat-Sen University
| 4 anni |
| Dmitry Samarsky | M | 57 | - | |
| Zhi Jun Liu | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Zhiming Lu | M | - |
Sun Yat-Sen University
| 5 anni |
| Jie Pin Fu | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Wei Cheng Diao | M | 60 |
Sun Yat-Sen University
| 4 anni |
| Chaohui Liu | F | - |
Sun Yat-Sen University
| 4 anni |
| Yan Zhang Jiang | M | 69 |
Sun Yat-Sen University
| 4 anni |
| Wu Qing Lu | F | 56 |
Sun Yat-Sen University
| 4 anni |
| Haibin Zheng | M | - |
Sun Yat-Sen University
| 4 anni |
| Yue Qiu | M | 55 |
Sun Yat-Sen University
| 4 anni |
| Bin Lin | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Ru Feng | M | 64 |
Sun Yat-Sen University
| 2 anni |
| Ping Liu | M | 55 |
Sun Yat-Sen University
| 4 anni |
| Ying Fan | F | - |
Sun Yat-Sen University
| 4 anni |
| Huan Xin Hu | M | 56 |
Sun Yat-Sen University
| 3 anni |
| Zhen Cheng Xu | M | 72 |
Sun Yat-Sen University
| 4 anni |
| Li Li | F | 58 |
Sun Yat-Sen University
| 4 anni |
| Guang Rui Ge | F | 57 |
Sun Yat-Sen University
| 4 anni |
| Xiao Hai Chen | M | 56 |
Sun Yat-Sen University
| 4 anni |
| Jian Xiong Liu | M | 53 |
Sun Yat-Sen University
| 4 anni |
| Shu Chen | F | 70 |
Sun Yat-Sen University
| 4 anni |
| Shui Sheng Liang | M | 59 |
Sun Yat-Sen University
| 4 anni |
| Xiu Nan Cai | M | - |
Sun Yat-Sen University
| 4 anni |
| Chong Liu | M | 54 |
Sun Yat-Sen University
| 4 anni |
| Chu Yuan Li | M | 58 |
Sun Yat-Sen University
| 4 anni |
| Feng Lian Zhu | F | 60 |
Sun Yat-Sen University
| 4 anni |
| Yao De Zeng | M | 57 |
Sun Yat-Sen University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 84 | 84.00% |
| Hong Kong | 16 | 16.00% |
| Stati Uniti | 7 | 7.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Patrick Lu
- Contatti personali
